The worldwide fiber supplements market is expected to be valued at US$ 34.18 billion by 2032, up from US$ 18.21 billion in 2022, with a 6.5% CAGR over the forecast period. Fiber is a type of carbohydrate that helps to keep the digestive systems healthy. There are numerous fiber supplements available in the industry in various forms, such …
Author Archives: Editor AN
Lactose Free Probiotic Yogurt Market Study on Competition Dashboard and Forecast by 2032
The global lactose free probiotic yogurt market is forecasted to be appraised at US$ 25.05 billion by 2032, up from US$ 13.6 billion in 2022, advancing at a CAGR of 6.3% during the forecast period. Lactose free probiotic yogurt is made without milk’s sugar lactose, and the market includes cheese, yogurt, desserts, and ice creams that are comprised of very less or no lactose …
Natural Source Vitamin E Market Growth Study on Competition, Challenges & Supply Chain Overview by 2032
The natural source vitamin E market share leads to a moderate CAGR of 8% in the global market during the forecast period. Speaking of which, the global market retains a forecasted revenue of US$ 0.81 Bn in 2022 and is expected to cross US$ 1.75 Bn by 2032. From the aforementioned data analysis, the demand for natural source vitamin E is likely to …
Spinal Osteosynthesis Units Market is expected to grow at a steady CAGR of 4.8% between 2022 and 2032 | Says FMI
[Report of 250 Pages] Around US$ 2.8 billion was spent on spinal osteosynthesis units globally in 2021. The market is anticipated to grow at a steady CAGR of 4.8% between 2022 and 2032, surpassing US$ 3.9 Billion by that year due to the rapid increase in spinal surgeries and rising incidence of spinal conditions like lumbar spondylosis, …
INR Test Meter Market is expected to reach US$ 2.4 Billion by the end of 2032 | Exclusive Report by FMI
[300+ Pages Report] The market for INR test metres is anticipated to reach US$ 1.3 billion by the end of 2022, growing at a CAGR of 6.3 percent, and surpassing US$ 2.4 billion by 2032. With a market share of approximately 79.7% in 2021, the devices segment dominated the global INR test metre market in …
Brain Tumor Drugs Market is projected to be worth US$ 6.30 billion in 2033 | Get Insights FMI
From 2023 to 2033, the market for drugs for brain tumors is anticipated to grow at a 9.2% CAGR. Market value is anticipated to reach US$ 2.65 billion in 2023 and US$ 6.30 billion in 2033. The Brain Tumor Drugs Market is likely to grow from US$ 2.65 billion in 2023 to US$ 6.30 billion in …
Cartilage Repair Market is projected to have an effective CAGR of 13.9% from 2022 to 2032 | FMI
The global Cartilage Repair Market is expected to reach a value of US$ 3.9 Bn by 2032, with the market growing at a stellar CAGR of 13.9% from 2022 to 2032. Scaling up from a value of US$ 1.60 Bn in 2021, the target market is set to reach an estimated US$ 1 Bn in 2022. …
Retractable Needle Safety Syringes Market is likely to grow at a steady CAGR of 4.0% between 2022 and 2032
[376 Pages Report] As per Future Market Insights’ latest industry analysis, the global Retractable Needle Safety Syringes Market was valued at around US$ 5.49 Bn in 2021 and is anticipated to reach US$ 8.45 Bn by 2032, exhibiting a CAGR of around 4.0% over the forecast period (2022-2032). Attribute Key Statistics Retractable Needle Safety Syringes Market Base Value (2021) US$ 5.49 Bn Projected Market …
Chronic Disease Management Market is expected to accumulate a value of US$ 17,267.6 Million by 2032, at a CAGR 13.4% from 2022 to 2032
[Report of 340 Pages] The global Chronic Disease Management Market was worth $4,315.3 million in 2022 and is expected to be worth $17,267.6 million by 2032, growing at a CAGR of 13.4% during the forecast period. Chronic disease management services are also referred as enhance primary care. This service is provided to the patient suffering …
IgA Nephropathy Market value of US$ 85 Billion by registering a CAGR of 7.5% from 2023 to 2033
During the forecast period 2023 to 2033, the IgA Nephropathy Market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion. Key factors such as high prevalence of …